Effects of medicinal cake-separated moxibustion on plasma 6-keto-PGF1alpha and TXB2 contents in the rabbit of hyperlipemia

J Tradit Chin Med. 2005 Jun;25(2):145-7.

Abstract

Hyperlipemia rabbit models established with high cholesterol and fat diet were treated with direct moxibustion and medicinal cake-separated moxibustion. The post-treatment plasma 6-keto-prostaglandin F1alpha (6-keto-PGF1alpha) and thromboxane B2 (TXB2) contents were determined by radioimmunoassay. Results indicated that the plasma 6-keto-PGF1alpha content significantly increased, the TXB2 level decreased (P < 0.05) and the TXB2 /6-keto-PGF1alpha ratio also decreased (P < 0.01) in the medicinal cake-separated moxibustion group as compared with those in the model group respectively, but there was no significant difference between the medicinal cake-separated moxibustion group and the direct moxibustion group (P > 0.05), suggesting that both the medicinal cake-separated moxibustion and direct moxibustion can regulate the plasma 6-keto-PGF1alpha and TXB2 contents, and the TXB2/6-keto-PGF1alpha ratio with similar actions, and have a certain protective action on endothelial cells of the aorta in the rabbit of hyperlipemia.

Publication types

  • Comparative Study

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / blood*
  • Animals
  • Female
  • Hyperlipidemias / blood
  • Hyperlipidemias / therapy*
  • Male
  • Moxibustion* / methods
  • Rabbits
  • Radioimmunoassay
  • Thromboxane B2 / blood*

Substances

  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha